MAPT and Alzheimer disease: Recent large-scale genome-wide association studies, including the work by Bellenguez et al. [11], have identified 75 AD risk loci, 42 of which were novel, highlighting not only classical amyloid/tau pathways but also the involvement of microglial functions.